Vancouver, Canada – Rostrum Medical Innovations, a medical device company focused on the development of useful links between medicine and engineering, today announced the appointment of Scott Phillips to its Board of Directors, effective April 1, 2021. Click here to view full release.
Vancouver, Canada – Rostrum is pleased to announce its successful transition into human clinical trials. The first subjects were successfully enrolled using the Rostrum VQm Pulmonary Health Monitor at UC Davis (California) last week. Previously, Rostrum has completed extensive in-vivo animal testing in California, Vienna and Paris. Click here to view full release.
Vancouver, BC Canada – December 1, 2020 – Rostrum Medical will attend the 33rd annual European Society of Intensive Care Medicine (“ESICM”) LIVES Digital congress. The digital congress will commence on December 6th and run through December 9th, 2020. The ESICM has an outstanding program of exceptional science that is both interactive, innovative and informative,…
Rostrum’s Efforts to address COVID-19 challenges: As the world is facing unprecedented changes and challenges, Rostrum supports all affected individuals during this challenging time. The Rostrum team has been closely monitoring the consistently developing situation surrounding the outbreak of COVID-19. Further to Rostrum’s update in August 2019, Rostrum is pleased to announce its progress on…
Toronto, ON and Vancouver, BC Canada – November 29, 2017 – Thornhill and Rostrum celebrate the finalization of a Technology Development Agreement which includes the licensing of certain Thornhill IP and an investment by Rostrum into Thornhill. This agreement is aimed to further Rostrum’s development of its Pulmonary Health Monitoring during ventilation, in ICU, OR…
Rostrum Medical Innovations Inc., a Canadian medical device developer announced that it has completed its ‘Series A’ offering being fully subscribed by Yonghua Investment Management Co., Ltd. (“Yonghua Capital”) of Shanghai, PRC. August2016-RostrumCompletes